Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology
Top Cited Papers
- 17 February 2013
- journal article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 125 (4), 511-522
- https://doi.org/10.1007/s00401-013-1090-0
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansionActa Neuropathologica, 2012
- Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosisActa Neuropathologica, 2012
- p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALSActa Neuropathologica, 2011
- Regulation of TDP-43 aggregation by phosphorylation andp62/SQSTM1Journal of Neurochemistry, 2010
- Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of boneNature Genetics, 2010
- Paget's Disease of Bone in the French Population: Novel SQSTM1 Mutations, Functional Analysis, and Genotype–Phenotype CorrelationsJournal of Bone and Mineral Research, 2007
- Loss of Ubiquitin Binding Is a Unifying Mechanism by Which Mutations of SQSTM1 Cause Paget’s Disease of BoneCalcified Tissue International, 2006
- Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin–proteasome degradationNature, 2001
- El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2000
- The Epidemiology of Paget's Disease in Britain: Is the Prevalence Decreasing?Journal of Bone and Mineral Research, 1999